Financing ·
Picard Medical issues 200,000 shares to cancel warrants previously exercisable for over 8.1 million shares
PMIPicard Medical, Inc.
On October 22, 2026, Picard Medical issued 200,000 shares of common stock to the placement agent and its employee designee in exchange for the surrender of all outstanding warrants from a December 2025 private placement. The warrants were previously exercisable for 8,187,766 shares following a 1-for-50 reverse stock split effective July 31, 2026. No cash consideration was paid by either party, and the company relied on an exemption from registration under Section 3(a)(9) of the Securities Act. The transaction fully satisfied and discharged the warrants, which were automatically cancelled. Picard Medical develops and manufactures medical devices for minimally invasive procedures.